Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 3, 2008Company announces management changes and further organizational consolidation
Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin will be extending his tenure at the...
-
May 29, 2008Environmentally focused improvements are hallmark of renovations to Endosurgery headquarters
Boston Scientific Corporation (NYSE: BSX) today announced it has received Leadership in Energy and Environmental Design (LEED) certification from...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) and CryoCor, Inc. (NASDAQ: CRYO) today announced that Boston Scientific has completed its...
-
May 28, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that a U.S. District Court jury in Marshall, Texas has reached a verdict in a patent...
-
May 20, 2008Positive results presented at Digestive Disease Week® 2008
Boston Scientific Corporation (NYSE: BSX) today announced results from an international, multi-center patient registry documenting...
-
May 19, 2008New size allows for treatment of smaller-diameter diseased saphenous vein grafts
Boston Scientific Corporation (NYSE: BSX) today announced the launch of its FilterWire EZ™ Embolic Protection System in a new 2.25 - 3.5 mm size,...
-
May 16, 2008ACUITY® Spiral lead has smallest left ventricular lead tip profile in the industry
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its ACUITY® Spiral left ventricular...
-
May 16, 2008Results of international, multi-center registry presented at conference
Boston Scientific Corporation (NYSE: BSX) today announced that results from an international, multi-center patient registry documenting the safety...
-
May 15, 2008ALTITUDE clinical science initiative will provide insights to ICD and CRT-D device therapy
Boston Scientific Corporation (NYSE: BSX) today announced a new clinical science initiative, ALTITUDE, which will analyze data(1) from the...
-
May 13, 2008COGNIS™ CRT-D and TELIGEN™ ICD represent entirely new platforms
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) approval of its COGNIS™ cardiac...